By Viviane Trojan

We are pleased to announce that we have been ranked by Leaders League Brasil, a reputable legal publication, for another year. In … Kasznar Leonardos was ranked by Leaders League Brasil 2024

We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2024 Global Practice Guide! Our partners Priscila Kashiwabara … Life Sciences’ Brazil Global Guide 2024 is now available

On Tuesday, June 4, 2024, the Brazilian Patent and Trademark Office (”INPI”) published its Integrity Plan, outlining actions to manage integrity risks … BRPTO Publishes Integrity Plan for 2024-2025

Anvisa approved the new simplified regulation for the registration of biosimilar medicines, whose publication in the Official Gazette (DOU) is still awaited. … New Regulation Approved by Anvisa Simplifies the Registration Process for Biosimilar Medicines

Our partner Viviane Trojan was invited by the International Bar Association (IBA) to write an article for their platform. She authored the … Trade secrets: a strategic element in the life sciences and biotechnology industries

In celebration of World Intellectual Property Day, we invite you to delve into ‘Brazilian Patent Litigation: 2022/2023 in Review,’ a collaborative effort … Celebrating the World Intellectual Property Day, Kasznar Leonardos launches Brazilian Patent Litigation Guide

Anvisa recently launched a public notice with the aim of selecting Startups involved in the research and development of medicines, in order … Anvisa opens its doors to Startups: Stepping towards Innovation in Medicines

Kasznar Leonardos is proud to be a contributor to the Legal 500’s “Brazil: Life Sciences” guide. Our partners Priscila Kashiwabara and Viviane … Kasznar Leonardos contributes to the “Brazil: Life Sciences” guide by The Legal 500

As announced by our firm in our Newsletter No. 67 of December 15, 2023, a position of the INPI’s Federal Attorney’s Office, … Brazilian Patent and Trademarks Office (INPI) allows amendments to patent applications during the appeal phase, subject to new criteria

We are pleased to announce that our partners Gabriel Leonardos, Claudio Barbosa and Viviane Trojan, alongside attorneys at law Jorge Tinoco and … Chambers and Partners’ Patent Litigation Guide 2024 is now available!

ANVISA’s new Regulatory Agenda 2024-2025 (RA 24/25) was approved and published on the Official Gazette on December 18th. The Joint Ordinance No. … 2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA

As recently reported, the BRPTO announced a series of new guidelines regarding the processing of patent, trademark and industrial design applications. Check … Industrial Design Registration: new BRPTO opinion on the scope of appeal

On Tuesday, December 12, 2023, the BRPTO published new rules that limit applicants’ acts in the administrative process for granting patents. At the … The BRPTO ruled that it is not possible to amend a patent application during the appeal phase

Starting February 6, 2024, generic and branded-generic (“similar”) drugs will be allowed to have different labels than their respective standard labels with … Anvisa approves skinny labeling practice in Brazil

The Interministerial Group on Intellectual Property (“GIPI’, in the Portuguese acronym), has announced its 2023-2025 Action Plan for implementing the Brazilian Intellectual … 2023 – 2025 Action Plan for the Brazilian Intellectual Property National Strategy Announced by GIPI